ChemPath: Porphyrias Flashcards

1
Q

What is porphyria?

A
  • Disorders caused by deficiencies in enzymes of the haem synthesis pathway
  • This leads to the accumulation of toxic haem precursors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two ways in which porphyria can manifest?

A
  • Acute neuro-visceral attacks
  • Acute or chronic cutaneous symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some key features of haem.

A
  • Organic heterocyclic compound with Fe2+ in the centre
  • 4 tetrapyrrole rings around the iron

tetrapyrrole ring - nitrogen with 4 carbons arounud it in ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where is haem made?

What is its importance

A

made in every single cell –> by ALA synthase

haem then used to make cytochrome –> needed for electron transport in aerobic respiration

without it we would die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what cells do porphyrias affect

A

haem synthesesis in eythroid cells and liver cytochrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Draw the haem synthesis pathway.

A

Grey box is mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which component of the haem biosynthesis pathway is neurotoxic?

Clinical Relevance of this?

A

5-ALA
Accumulation –> neuro-visceral symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What types of porphyrin may be produced in the absence of iron?

A
  • Metal-free protoporphyrins
  • Zinc protoporphyrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can porphyrias be classified?

A

Principle site of enzyme deficiency:

  • Erythroid
  • Hepatic

Clinical presentation:

  • Acute or non-acute
  • Neurovisceral or skin lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline the relationships between UV light and skin lesions.

A

Porphyrinogens are oxidised and then activated by UV light into activated porphyrins —> blistering/non blistering cutaenous presentations

NOTE: porphyrinogens do NOT oxidise in cells, it occurs in circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a key difference between porphyrinogens and porphyrins?

A

Porphrinogens are pre-cursors to porphyrin

  • Porphyrinogens - colourless, unstable and readily oxidised to porphyrin (no double bonds)
  • Porphyrins - highly coloured (have double bonds)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which porphyrins appears in the urine and faeces?

A
  • Urine - uroporphyrins are water soluble
  • Faeces - coproporphyrins are less soluble and near the end of the pathway

NOTE: someone with porphyria will have colourless/yellow urine which turns red/dark red/purple as the porphyrinogens are oxidised and activated into porphyrins

NOTE: haem synthessis pathway –> early porphyrins are water soluble, later are less soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List four types of acute porphyria and the enzymes involved.

A
  • Plumboporphyria - PBG synthase
  • Acute intermittent porphyria - HMB synthase / PBG deaminase
  • Hereditary coproporphyria - coproporphyrinogen oxidase
  • Variegate porphyria - protoporphyrinogen oxidase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the most common porphyrias

A
  1. Porphyria cutanea tarda
  2. Acute intermittent porphyria –> these patients very sick in A&E
  3. Erythropeoitic protoporphyria –> most common porphyria in children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List three types of non-acute porphyria and the enzymes involved.

A
  • Congenital erythropoietic porphyria - uroporphyrinogen III synthase
  • Porphyria cutanea tarda - uroporphyginogen decarboxylase
  • Erythropoietic protoporphyria - ferrochetolase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the most common type of porphyria?

A

Porphyria cutanea tarda

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the most common type of porphyria in children?

A

Erythropoietic protoporphyria

18
Q

What does ALA synthase deficiency cause?

A

X-linked sideroblastic anaemia

19
Q

How can a mutation in ALA synthase lead to porphyria?

A

A gain-of-function mutation –> increased activity of ALA synthase

Increased throughput through the pathway –> ferrochetolase is overwhelmed –> build up of protoporphyrin IX

very rare, dont focus on it

20
Q

What are the main features of PBG synthase deficiency?

A
  • Causes plumboporphyria
  • Leads to accumulation of ALA

Acute neuro-visceral symptoms:
* Abdominal pain (most presenting important feature)
* Neurological symptoms (e.g. coma, bulbar palsy, motor neuropathy)

Extrememly rare

21
Q

Which deficiency causes acute intermittent porphyria?

A

HMB synthase (aka PBG deaminase)

22
Q

Outline the clinical features of acute intermittent porphyria.

A
  • Rise in PBG and ALA
  • Autosomal dominant
  • Neurovisceral attacks (due to ALA accumulation)
    • Abdominal pain
    • Tachycardia and hypertension
    • Constipation, urinary incontinence
    • Hyponatraemia and seizures
    • Sensory loss/muscle weakness
    • Arrythmias/cardiac arrest

Important: there are NO skin symptoms (because no porphyrinogens are produced)

NOTE: 90% will be asymptomatic

23
Q

List some precipitating factors for acute intermittent porphyria.

A
  • ALA synthase inhibitors (e.g. steroids, ethanol, anticonvulsants - CYP450 inducers
  • Stress (infection, surgery)
  • Reduced caloric intake
  • Endocrine factors
24
Q

Describe how acute intermittent porphyria is diagnosed.

A
  • increased urinary PBG (and ALA)
  • PBG gets oxidised to porphobilin by light - goes from yellow to purple
  • Decreased HMB synthase activity in erythrocytes

shield urine from light!!

25
Q

How is acute intermittent porphyria managed?

A
  • Avoid attakcs (adequate nutrition, avoid precipitant drug, prompt treatment of other illnesses)
  • IV carbohydrate (inhibits ALA synthase)
  • IV haem arginate (switches off haem synthesis through negative feedback)

NOTE: adequate carbs important, as low carb can trigger attack

26
Q

Name two acute porphyrias that have skin manifestations. State the enzymes affected.

How would they be diagnosed

A
  • Hereditary coproporphyria - coproporphyrinogen oxidase
  • Variegate porphyria - protoporphyrinogen oxidase

Stool samples –> excess coproporphyrinogen II and protophorphoryinogen IX in stool (they’re less water soluble)

27
Q

What is the negative consequence of accumulation of coproporphyrinogen III and protoporphyrinogen IX?

A
  • They are potent inhibitors of HMB synthase
  • Results in the accumulation of PBG and ALA –> acute neuro-visceral attacks

skin manifestations due to porphyrinogen buiild up as well

28
Q

What are the main clinical features of hereditary coproporphyria?

A
  • Autosomal dominant
  • Acute neurovisceral attacks
  • Skin lesions (blistering, skin fragility, classically on the backs of the hands that tend to appear hours/days after sun exposure)

blisters on back of hand due to sun exposure

29
Q

What are the main clinical features of variegate porphyria?

A
  • Autosomal dominant
  • Acute attacks with skin lesions

less severe than hereditary coproporphyria

30
Q

diagnosis of acute porphyrias

A

send off urine in acute attack (protected from light) –> urine PBG raised in all 3 (not in Plumboporphyria (PBG synthase deficiency) as pathway doesn’t get that far)

  • AIP - normal - no porphyrins in urine/feces (pathway doesn’t get that way)
  • HCP and VP - high porphyrin in urine/feces

Clinically:
AIP –> no skin lesions, but HCP and VP do have skin lesions

NOTE: DNA analysis offers a definitive diagnosis

31
Q

what are the acute porphyrias

A

Acute intermittent porphyria - neurovisceral attacks
Hereditary coproporphyria - neurovisceral attacks + blistering skin lesions
Variegate porphyria - neurovisceral attacks + blistering skin lesions

Plumboporphyria - PBG synthase

32
Q

What is a common feature of non-acute porphyria?

A

Only present with skin lesions with NO neurovisceral manifestations

33
Q

What are the non-acute porphyrias

A
  • Uroporphyrinogen III synthase - congenital erythropoietic porphyria
  • Uroporphyrinogen decarboxylase - porphyria cutanea tarda
  • Ferrochetolase - erythropoietic protoporphyria
34
Q

What is the main flinical feature of non-acute porphyria?

A
  • Only skin affected!!
  • Blisters in Porphyria cutanea tarda, Congenital erythropoietic porphyria
  • No blisters in erythropoietic protoporphyria
  • Skin fragility, pigmentations and erosions
  • Occuring hours to days after sun exposure
35
Q

What are the key features of erythropoietic protoporphyria?

How is it managed

A

NON-blistering and presents with photosensitivity, burning, itching, oedema minutes following sun exposure

Sun avoidance

36
Q

What is a key investigation for erythropoietic protoporphyria?

A

RBC protoporphyrin

NOTE: only RBCs are affected

i.e. porphyrins won’t be high in urine/feces

37
Q

What are the key features of porphyria cutanea tarda?

A
  • Can be inherited or acquired (liver disease, HIV, drugs)
  • Leads to formation of blisters on sun-exposed areas of skin crusting, superficial scarring and pigmentation
38
Q

Outline the biochemistry features of porphyria cutanea tarda.

A
  • Urine/plasma uroporphyrins and coproporphyrins are raised
  • Ferritin is often increased
39
Q

Which drug can trigger porphyria cutanea tarda?

A

Hexachlorobenzene (fungicide for seeds)

40
Q

What haematological condition are erythropoietic protoporphyria and congenital erythropoietic porphyria associated with?

A

Myelodysplastic syndromes

41
Q

During acute porphyria, what is the most uesful sample to send?

A

Urine